综合生物信息学分析和NLRP12的实验研究揭示了其在卵巢癌中的预后价值和潜在功能
Zhihui Xie1, Tiantian Yang2,3, Chuchu Zhou2,3
1Department of Medical Oncology, Huaihe Hospital of Henan University, Kaifeng, China.
Molecular carcinogenesis
|November 27, 2024
概括
在卵巢癌 (OV) 中,NLRP12的升高调节,与预后不佳和免疫细胞透率增加相关. 向NLRP12可能会改善OV患者的免疫治疗反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- NLRP12是细胞功能,免疫平衡,炎症和瘤发生的关键调节剂.
- 它在瘤微环境 (TME) 和卵巢癌 (OV) 的异质性中的特定作用需要进一步阐明.
研究的目的:
- 为了研究卵巢癌中NLRP12的表达和功能.
- 确定NLRP12与瘤微环境,预后和OV免疫疗法反应之间的关系.
主要方法:
- 使用各种数据库和临床标本进行生物信息分析.
- 试验室试验评估NLRP12对OV细胞增殖和侵入的影响.
- 对癌症免疫组图谱 (TCIA) 数据库和动物实验的分析.
主要成果:
- 在OV中NLRP12是上调调节的,并且与预后不佳有关.
- 高NLRP12表达与增加的免疫细胞透和免疫检查点分子相关.
- 较低的NLRP12表达可能预测增强的免疫疗法反应,特别是对CTLA4抑制剂.
- 在OV细胞中,NLRP12促进了上皮-介质细胞转换 (EMT).
- 斯基桑德林B (Schi B) 通过向SPI1.1,减少NLRP12的表达.
结论:
- NLRP12是卵巢癌预后不佳的重要免疫相关生物标志物.
- 准NLRP12为OV提供了一个潜在的治疗策略.
相关概念视频
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K


